✦ LIBER ✦

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with ‘black holes’, disease duration and clinical disability

✍ Scribed by Andrea Paolillo; Carlo Pozzilli; Claudio Gasperini; Elisabetta Giugni; Caterina Mainero; Saverio Giuliani; Valentina Tomassini; Enrico Millefiorini; Stefano Bastianello

Book ID: 119465100
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 87 KB
Volume: 174
Category: Article
ISSN: 0022-510X
DOI: 10.1016/s0022-510x(00)00259-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationships of brain white matter micr

Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis

✍ Antonio Giorgio; Jacqueline Palace; Heidi Johansen-Berg; Stephen M. Smith; Stefa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 1 views

Gray matter atrophy and disability progr

Gray matter atrophy and disability progression in patients with early relapsing–remitting multiple sclerosis: A 5-year longitudinal study

✍ Dana Horakova; Michael G. Dwyer; Eva Havrdova; Jennifer L. Cox; Ondrej Dolezal; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 288 KB

PND7 Disability Progression in Patients

PND7 Disability Progression in Patients with Relapsing Remitting Multiple Sclerosis (RRMS) Who Experience Disease Activity Despite Previous Disease Modifying Therapy

✍ R. Hettle; J. Murphy; B. Eckert 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Regional Brain Atrophy Is Associated Wit

Regional Brain Atrophy Is Associated With Physical Disability in Multiple Sclerosis: Semiquantitative Magnetic Resonance Imaging and Relationship to Clinical Findings

✍ Rohit Bakshi; Ralph H. B. Benedict; Robert A. Bermel; Lawrence Jacobs 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Effect of natalizumab on clinical and ra

Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis

✍ Melin, A.; Outteryck, O.; Collongues, N.; Zéphir, H.; Fleury, M. C.; Blanc, F.; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 305 KB

PNL1 CLINICAL EFFECTIVENESS AND HEALTH O

PNL1 CLINICAL EFFECTIVENESS AND HEALTH OUTCOMES OF DISEASE MODIFYING TREATMENT (DMT) THAT DELAYS DISABILITY PROGRESSION IN RELAPSING/REMITTING-ONSET MULTIPLE SCLEROSIS: NOVA SCOTIA “REAL WORLD” EVIDENCE

✍ MG Brown; S Kirby; JD Fisk; IS Sketris; J Hoch; V Bhan; TJ Murray; C Skedgel; D 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB